Paul is the Chairman and Founder of The Brooks Group. Paul began his career in the pharmaceutical industry at Smith, Kline & French (later merging to become SmithKline Beecham). At SmithKline Beecham (SB), Paul excelled in sales and marketing assignments and was consistently recognized for his accomplishments in the pharmaceutical and healthcare industries. In 1986, Paul was appointed to the team that designed and implemented the first national accounts group in the pharmaceutical industry.
Paul also developed the first capitation program offered by a pharmaceutical company. The program capitated H2 antagonists in hospital systems and became the model SB utilized for the positioning of Tagamet in the managed care marketplace.
Promoted to the position of Group Director of National Accounts for SB, Paul was responsible for a sales budget of more than $1 billion, overseeing 18 national account executives. His team led all market segments in the managed care marketplace. During his tenure, SB was consistently ranked as one of the top national account programs in the pharmaceutical industry.
After 12 years, Paul moved on from SB to become a partner in the marketing consulting company, Marketing Outcomes. Paul has consulted with many of the largest pharmaceutical companies in the world regarding management, strategy development, and national account manager deployment and training.
He is often asked to speak at pharmaceutical industry meetings and offer his opinions on managed care and the healthcare industry.
Paul is a graduate of the University of Kentucky School of Pharmacy.